Preclinical studies in both mice and rats show that not only does short-term treatment with modafinil promote DG hippocampal neurogenesis and decrease cell death, but also normalizes brain-derived neurotrophic factor (BDNF) expression, which is known to be deficient in individuals with AD [60, 61]. This evidence concerns the gene BDNF and Alzheimer disease.